Zhang Xinyu, Clark Abbot F, Yorio Thomas
Department of Pharmacology and Neuroscience, University of North Texas Health Science Center, Fort Worth, Texas 76107, USA.
Invest Ophthalmol Vis Sci. 2008 Mar;49(3):1037-47. doi: 10.1167/iovs.07-1279.
A spliced variant of the human glucocorticoid receptor GRbeta has been implicated in glucocorticoid responsiveness in glaucoma. Over-expression of the FK506-binding immunophilin FKBP51 also causes a generalized state of glucocorticoid resistance. In the present study, the roles of FKBP51 in the nuclear transport of GRbeta and glucocorticoid responsiveness were investigated.
Human trabecular meshwork cells (GTM3 and TM5) and HeLa cells were treated with dexamethasone (DEX) and FK506 and transfected with GRbeta and FKBP51 expression vectors. Coimmunoprecipitation and Western blot analyses were performed to study interactions of FKBP51 and FKBP52 with GRalpha, GRbeta, Hsp90, or dynein. The cells were transfected with a GRE-luciferase reporter to evaluate the effects of DEX and FK506 and the overexpression of GRbeta and FKBP51 on glucocorticoid-mediated gene expression.
FKBP51 was involved in constitutive nuclear transport of both GRalpha and -beta in the absence of ligands. FKBP52 appeared to be solely responsible for the nuclear transport of ligand-activated GRalpha. DEX stimulated the translocation of GRalpha but not GRbeta. Overexpression of either GRbeta or FKBP51 stimulated GRbeta translocation and reduced DEX-induced luciferase in HeLa cells. FK506 did not alter DEX-induced translocation of GRalpha. However, FK506 increased the association of FKBP51 with GRbeta and stimulated DEX-induced translocation of GRbeta in normal TM cells, but not in glaucoma TM cells. Increased nuclear GRbeta significantly inhibited glucocorticoid responsiveness in TM cells.
Nuclear transport of GRbeta represents a novel mechanism through which FKBP51 alters GC sensitivity. GRbeta and FKBP51 may be responsible for increased responsiveness in steroid-induced ocular hypertensive individuals as well as in patients with glaucoma.
人糖皮质激素受体GRβ的一种剪接变体与青光眼的糖皮质激素反应性有关。FK506结合亲免素FKBP51的过表达也会导致全身性糖皮质激素抵抗状态。在本研究中,研究了FKBP51在GRβ核转运和糖皮质激素反应性中的作用。
用人小梁网细胞(GTM3和TM5)和HeLa细胞分别用 dexamethasone(DEX)和FK506处理,并转染GRβ和FKBP51表达载体。进行免疫共沉淀和蛋白质印迹分析,以研究FKBP51和FKBP52与GRα、GRβ、Hsp90或动力蛋白的相互作用。用GRE荧光素酶报告基因转染细胞,以评估DEX和FK506以及GRβ和FKBP51过表达对糖皮质激素介导的基因表达的影响。
在没有配体的情况下,FKBP51参与GRα和GRβ的组成型核转运。FKBP52似乎是配体激活的GRα核转运的唯一负责者。DEX刺激GRα的易位,但不刺激GRβ的易位。GRβ或FKBP51的过表达刺激HeLa细胞中GRβ的易位并降低DEX诱导的荧光素酶活性。FK506不改变DEX诱导的GRα易位。然而,FK506增加了FKBP51与GRβ的结合,并刺激正常小梁网细胞中DEX诱导的GRβ易位,但在青光眼小梁网细胞中则不然。核内GRβ的增加显著抑制小梁网细胞中的糖皮质激素反应性。
GRβ的核转运代表了FKBP51改变糖皮质激素敏感性的一种新机制。GRβ和FKBP51可能是类固醇诱导的高眼压个体以及青光眼患者反应性增加的原因。